{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:02:01Z","timestamp":1787724121078,"version":"build-2784847793"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Accurate estimation of conception is critical in the assessment of the effects of drugs used during pregnancy or to prevent pregnancy. In a novel application, we studied the effectiveness of oral contraceptives (OCs), where misclassification of conception relative to OC exposure may obscure effect estimates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We studied OC failure, in a large claims database, among women who used antiepileptic drugs with metabolizing enzyme-inducing properties (carbamazepine or oxcarbazepine), which reduce OC\u2019s effectiveness or enzyme-neutral properties (lamotrigine or levetiracetam), with no expected impact on OC effectiveness. We compared conception rates in women 12\u201348 years of age concomitantly using OCs and enzyme-inducing drugs with rates in concomitant users of OCs and enzyme-neutral drugs. We measured conception with a validated algorithm that estimates gestational age based on pregnancy endpoints. We estimated relative and attributable risk using generalized estimating equation models after standardized mortality ratio weighting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We identified 89,777 concomitant use episodes with adjusted contraceptive failure rates of 1.6 (95% confidence interval (CI) = 1.4, 1.8) per 100 person\u2013years among users of enzyme-neutral drugs and 18,964 episodes with a rate of 2.3 (1.9, 2.8) among users of enzyme-inducing drugs. The relative risk of conception for enzyme-inducing group was 1.4 (1.1, 1.8), and the rate difference was 0.7 (0.2, 1.2).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>OCs in combination with antiepileptic drugs that interact with metabolic enzymes were associated with increased contraceptive failure rates. Measurement of conception in claims data had adequate accuracy to uncover a strong drug\u2013drug interaction, offering promise for broader application in comparative effectiveness studies on hormonal contraceptives to inform clinical and regulatory decisionmaking.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ede.0000000000001302","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T23:23:05Z","timestamp":1605568985000},"page":"268-276","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["A Pharmacoepidemiologic Approach to Evaluate Real-world Effectiveness of Hormonal Contraceptives in the Presence of Drug\u2013drug Interactions"],"prefix":"10.1097","volume":"32","author":[{"given":"Amir","family":"Sarayani","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, FL"},{"name":"Center for Drug Evaluation and Safety, University of Florida, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, FL"},{"name":"Center for Drug Evaluation and Safety, University of Florida, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie J.","family":"Goodin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, FL"},{"name":"Center for Drug Evaluation and Safety, University of Florida, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Squires","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, FL"},{"name":"Center for Drug Evaluation and Safety, University of Florida, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, FL"},{"name":"Center for Drug Evaluation and Safety, University of Florida, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Cicali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, University of Florida, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Henriksen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, University of Florida, FL"},{"name":"Center for Pharmacometrics and Systems Pharmacology, University of Florida, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almut G.","family":"Winterstein","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, FL"},{"name":"Center for Drug Evaluation and Safety, University of Florida, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"R1-20250801","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1212\/WNL.0000000000004857","article-title":"Topiramate use early in pregnancy and the risk of oral clefts: a pregnancy cohort study.","volume":"90","author":"Hernandez-Diaz","year":"2018","journal-title":"Neurology"},{"key":"R2-20250801","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/jama.2018.18307","article-title":"Association of maternal first-trimester ondansetron use with cardiac malformations and oral clefts in offspring.","volume":"320","author":"Huybrechts","year":"2018","journal-title":"JAMA"},{"key":"R3-20250801","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/pds.4794","article-title":"Identifying pregnancies in insurance claims data: methods and application to retinoid teratogenic surveillance.","volume":"28","author":"MacDonald","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R4-20250801","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pds.3284","article-title":"Algorithms to estimate the beginning of pregnancy in administrative databases.","volume":"22","author":"Margulis","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R5-20250801","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/aje\/kwm367","article-title":"Sensitivity and specificity of computerized algorithms to classify gestational periods in the absence of information on date of conception.","volume":"167","author":"Toh","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R6-20250801","doi-asserted-by":"crossref","first-page":"e0192033","DOI":"10.1371\/journal.pone.0192033","article-title":"Inferring pregnancy episodes and outcomes within a network of observational databases.","volume":"13","author":"Matcho","year":"2018","journal-title":"PLoS One"},{"key":"R7-20250801","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1475-6773.2006.00635.x","article-title":"Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system.","volume":"42","author":"Hornbrook","year":"2007","journal-title":"Health Serv Res"},{"key":"R8-20250801","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/oxfordjournals.aje.a008790","article-title":"Timing and patterns of exposures during pregnancy and their implications for study methods.","volume":"143","author":"Hertz-Picciotto","year":"1996","journal-title":"Am J Epidemiol"},{"key":"R9-20250801","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/bmjqs-2019-010098","article-title":"Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate.","volume":"29","author":"Sarayani","year":"2020","journal-title":"BMJ Qual Saf"},{"key":"R11-20250801","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2125.1990.tb05457.x","article-title":"The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.","volume":"30","author":"Crawford","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"R12-20250801","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1528-1167.2010.02917.x","article-title":"Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation, and bleeding.","volume":"52","author":"Davis","year":"2011","journal-title":"Epilepsia"},{"key":"R13-20250801","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.contraception.2017.03.004","article-title":"The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users.","volume":"95","author":"Lazorwitz","year":"2017","journal-title":"Contraception"},{"key":"R14-20250801","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1528-1157.1999.tb00779.x","article-title":"Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women.","volume":"40","author":"Fattore","year":"1999","journal-title":"Epilepsia"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/AOG.0000000000003072","article-title":"American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 206: Use of hormonal contraception in women with coexisting medical conditions.","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R16-20250801","first-page":"1","article-title":"U.S. selected practice recommendations for contraceptive use, 2016.","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R17-20250801","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s40262-013-0088-z","article-title":"Drug interactions with the newer antiepileptic drugs (AEDs)\u2014part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders.","volume":"52","author":"Patsalos","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"R18-20250801","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s40262-013-0087-0","article-title":"Drug interactions with the newer antiepileptic drugs (AEDs)\u2014part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.","volume":"52","author":"Patsalos","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"R20-20250801","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/cpt.277","article-title":"Pharmacoepidemiologic methods for studying the health effects of drug-drug interactions.","volume":"99","author":"Hennessy","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"R21-20250801","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2147\/CLEP.S269400","article-title":"Impact of the transition from ICD-9-CM to ICD-10-CM on the identification of pregnancy episodes in US health insurance claims data.","volume":"12","author":"Sarayani","year":"2020","journal-title":"Clin Epidemiol"},{"key":"R22-20250801","first-page":"1","article-title":"Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract\u2014Quantifying the misclassification of maternal drug exposure during pregnancy.","author":"Zhu","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R23-20250801","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"R24-20250801","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/pds.3506","article-title":"A review of covariate selection for non-experimental comparative effectiveness research.","volume":"22","author":"Sauer","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R25-20250801","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/01.EDE.0000081989.82616.7d","article-title":"Marginal structural models as a tool for standardization.","volume":"14","author":"Sato","year":"2003","journal-title":"Epidemiology"},{"key":"R26-20250801","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy.","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception"},{"key":"R27-20250801","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1528-1157.1979.tb04834.x","article-title":"Do anticonvulsants reduce the efficacy of oral contraceptives?","volume":"20","author":"Coulam","year":"1979","journal-title":"Epilepsia"},{"key":"R29-20250801","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/13625187.2019.1629412","article-title":"Unintended pregnancy rates differ according to combined oral contraceptive\u2014results from the INAS-SCORE study.","volume":"24","author":"Barnett","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R30-20250801","doi-asserted-by":"crossref","first-page":"71.e1","DOI":"10.1016\/j.ajog.2016.01.162","article-title":"Risk of unintended pregnancy based on intended compared to actual contraceptive use.","volume":"215","author":"Reeves","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R31-20250801","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen.","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R32-20250801","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40471-014-0027-z","article-title":"Misclassification in administrative claims data: quantifying the impact on treatment effect estimates.","volume":"1","author":"Funk","year":"2014","journal-title":"Curr Epidemiol Rep"},{"key":"R33-20250801","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/pds.3264","article-title":"An algorithm to identify preterm infants in administrative claims data.","volume":"21","author":"Eworuke","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R34-20250801","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/AOG.0000000000001152","article-title":"Trends in stillbirth by gestational age in the United States, 2006-2012.","volume":"126","author":"MacDorman","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R35-20250801","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/aje\/kwy237","article-title":"Misclassification in assessment of first trimester in-utero exposure to drugs used proximally to conception: the example of letrozole utilization for infertility treatment.","volume":"188","author":"Bird","year":"2019","journal-title":"Am J Epidemiol"},{"key":"R36-20250801","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/ije\/dyu149","article-title":"Good practices for quantitative bias analysis.","volume":"43","author":"Lash","year":"2014","journal-title":"Int J Epidemiol"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:09:43Z","timestamp":1754060983000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001302","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,16]]}}}